MarketCap
Facebook
X
TelegramAnnual report 2024
added 01-03-2026
Midatech Pharma plc Operating Cash Flow 2011-2026 | MTP
Annual Operating Cash Flow Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -6.01 M | -9.3 M | -6.49 M | -13.4 M | -13 M | -13.1 M | -12.4 M | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.01 M | -13.4 M | -10.5 M |
Operating Cash Flow of other stocks in the Biotechnology industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AgeX Therapeutics
AGE
|
-7.8 M | - | -10.17 % | $ 12.2 K |  USA |
 |
MorphoSys AG
MOR
|
-481 M | - | 2.43 % | $ 254 M |  Germany |
 |
Pharming Group N.V.
PHAR
|
74 M | $ 17.07 | -1.28 % | $ 7.59 B |  Niderland |
 |
Alterity Therapeutics Limited
ATHE
|
-12.3 M | $ 3.32 | 7.79 % | $ 7.99 B |  Australia |
 |
AlloVir
ALVR
|
-67.7 M | - | 4.14 % | $ 49.1 M | USA |
 |
Immutep Limited
IMMP
|
-17.6 M | $ 2.9 | 1.22 % | $ 1.08 B | Australia |
 |
Biophytis SA
BPTS
|
-23.8 M | - | -13.47 % | $ 169 M |  France |
 |
Can-Fite BioPharma Ltd.
CANF
|
-7.64 M | $ 0.21 | 5.66 % | $ 457 M |  Israel |
 |
Aeglea BioTherapeutics
AGLE
|
-157 M | - | - | $ 1.01 B | USA |
 |
Ascendis Pharma A/S
ASND
|
-418 M | $ 212.56 | -0.32 % | $ 5 B |  Danmark |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-831 M | $ 10.81 | -4.21 % | $ 699 M | USA |
 |
Aclaris Therapeutics
ACRS
|
-20.1 M | $ 2.88 | -4.26 % | $ 223 M | USA |
 |
AIkido Pharma
AIKI
|
-15.1 M | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
-108 M | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-43.8 M | - | - | $ 2.17 B | USA |
 |
ARCA biopharma
ABIO
|
-57.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-8.56 M | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-93.9 M | - | - | $ 10.1 M | USA |
 |
Acasti Pharma
ACST
|
-14.9 M | - | 4.01 % | $ 150 M |  Canada |
 |
Anika Therapeutics
ANIK
|
-1.79 M | $ 9.41 | -2.08 % | $ 138 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-141 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
Athersys
ATHX
|
-76.2 M | - | 3.77 % | $ 22.4 M | USA |
 |
BioNTech SE
BNTX
|
890 M | $ 96.62 | 1.49 % | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
213 M | $ 26.33 | -1.68 % | $ 1.28 B | USA |
 |
Avenue Therapeutics
ATXI
|
-9.03 M | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-206 M | $ 1.9 | -4.5 % | $ 485 M | Britain |
 |
AVROBIO
AVRO
|
-63.2 M | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
41 M | - | -4.8 % | $ 255 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-452 M | - | -6.81 % | $ 3.04 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-141 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Acer Therapeutics
ACER
|
-30.3 M | - | 2.71 % | $ 14 M | USA |
 |
BioVie
BIVI
|
-19 M | $ 1.34 | 15.52 % | $ 1.98 M | USA |
 |
Axon Enterprise
AXON
|
408 M | $ 563.06 | -0.86 % | $ 42.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-34.5 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-1.94 M | $ 2.78 | 6.92 % | $ 17.5 M | USA |
 |
AstraZeneca PLC
AZN
|
5.96 B | $ 91.64 | -0.32 % | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
-25.8 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
-47.5 M | - | -7.31 % | $ 87 M | USA |
 |
Acorda Therapeutics
ACOR
|
-14 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
-4.34 M | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
181 M | $ 8.76 | -1.79 % | $ 1.47 B | Britain |
 |
bluebird bio
BLUE
|
-235 M | - | - | $ 546 M | USA |
 |
Biogen
BIIB
|
2.88 B | $ 177.33 | 0.76 % | $ 25.8 B | USA |
 |
Abeona Therapeutics
ABEO
|
-37 M | $ 5.28 | 0.27 % | $ 113 M | USA |
 |
ADiTx Therapeutics
ADTX
|
-16.8 M | $ 0.86 | 3.31 % | $ 11.3 K | USA |
 |
CureVac N.V.
CVAC
|
-733 M | $ 4.66 | 3.1 % | $ 867 M | Germany |